Provided by Tiger Trade Technology Pte. Ltd.

CINGULATE INC.

5.40
-0.4700-8.01%
Post-market: 5.450.0500+0.93%19:39 EDT
Volume:158.04K
Turnover:875.87K
Market Cap:78.53M
PE:-1.52
High:5.86
Open:5.86
Low:5.36
Close:5.87
52wk High:11.89
52wk Low:3.16
Shares:14.54M
Float Shares:14.11M
Volume Ratio:0.81
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5600
EPS(LYR):-4.4408
ROE:-198.74%
ROA:-66.94%
PB:3.35
PE(LYR):-1.22

Loading ...

Cingulate issues patent by USPTO for CTx-1301

TIPRANKS
·
Jun 16

Cingulate wins first US patent for ADHD drug CTx-1301, exclusivity to December 2042

Reuters
·
Jun 16

Cingulate director Jeff Hargroves acquires 97,276 common shares for $490,271.04

Reuters
·
Jun 09

Cingulate files Form 3 initial beneficial ownership statement for director Jeff Hargroves

Reuters
·
Jun 09

Cingulate Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Jun 08

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM

Reuters
·
Jun 02

Cingulate Faces FDA Delay But Maintains ADHD Drug Plans

TIPRANKS
·
Jun 02

FDA declines to approve Cingulate's ADHD treatment over manufacturing issues

Reuters
·
Jun 02

BRIEF-Cingulate Receives Complete Response Letter From FDA For CTx-1301

Reuters
·
Jun 02

Cingulate gets FDA complete response letter for ADHD drug CTx-1301 on CMC issues

Reuters
·
Jun 02

Cingulate - Has Nearly $30 Mln in Cash Reserves to Fund Operations Into 2027

THOMSON REUTERS
·
Jun 02

Cingulate Receives Complete Response Letter From FDA for Ctx-1301

THOMSON REUTERS
·
Jun 02

Cingulate - FDA Identifies Cmc Requests, No Current Safety or Efficacy Concerns for Ctx-1301

THOMSON REUTERS
·
Jun 02

Cingulate - Expects Prompt Submission of Requested Information to FDA

THOMSON REUTERS
·
Jun 02

Cingulate Receives Complete Response Letter from FDA for CTx-1301

GlobeNewswire
·
Jun 02

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Reuters
·
Jun 02

Cingulate Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
May 26

Analysts Are Bullish on These Healthcare Stocks: Roche Holding AG (RHHVF), Cingulate Inc (CING)

TIPRANKS
·
May 26

Cingulate Reshapes Board Structure and Leadership Roles

TIPRANKS
·
May 20

Cingulate says directors Ervin, Roberts won’t seek re-election at 2026 annual meeting

Reuters
·
May 20